Point of Care Diagnostics Market Size, Share, Scope, Forecast Report 2026 to 2035
Global Point of Care Diagnostics Market Segmentation
Global Point of Care Diagnostics Market Based on Products
- Glucose Monitoring Products
- Glucose Monitoring Strips
- Glucose Monitoring Meters
- Glucose Monitoring Lancets & Lancing Devices
- Cardiometabolic Monitoring Products
- Cardiac Marker Testing Products
- Blood Gas/Electrolyte Testing Products
- HbA1c Testing Products
- Infectious Disease Testing Products
- Respiratory Infection Testing Products
- Influenza Testing Products
- Tuberculosis
- Other Respiratory Infections
- Healthcare-Associated Infection Testing Products
- Tropical Disease Testing Products
- Sexually Transmitted Disease Testing Products
- HIV Testing Products
- Hepatitis Testing Products
- Syphilis Testing Products
- Human Papillomavirus Testing Products
- Chlamydia trachomatis Testing Products
- Neisseria gonorrhoeae Testing Products
- Herpes Simplex Virus Testing Products
- Clostridium difficile Infection Testing Products
- Other Infectious Disease Testing Products
- Coagulation Monitoring Products
- PT/INR Testing Products
- ACT/APTT Testing Products
- Pregnancy & Fertility Testing Products
- Pregnancy Testing Products
- Fertility Testing Products
- Tumor/Cancer Marker Testing Products
- Urinalysis Testing Products
- Cholesterol Testing Products
- Hematology Testing Products
- Drugs-of-Abuse Testing Products
- Thyroid-Stimulating Hormone Testing Products
- Fecal Occult Testing Products
- Other Products
Global Point of Care Diagnostics Market Based on Mode of Purchase
- Prescription-Based Testing Products
- Over-the-Counter (OTC) Testing Product
Global Point of Care Diagnostics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Technology
-
- Biochemistry
- Immunoassays
- Molecular Diagnostics
- RT-PCR
- INAAT
Global Point of Care Diagnostics Market Based on Sample Type
- Blood Samples
- Nasal & Oropharyngeal Swabs
- Urine Samples
- Other Samples
Global Point of Care Diagnostics Market Based on End-users
- Home Care/Self Testing
- Physician offices & Outpatient/Ambulatory Care Settings
- Hospitals
- Research Laboratories
Global Point of Care Diagnostics Market Based on Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America
- U.S.
- Canada
Europe
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Point of Care Diagnostics Market Snapshot
Chapter 4. Global Point of Care Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2026-2035
4.8. Global Point of Care Diagnostics Market Penetration & Growth Prospect Mapping (US$ Mn), 2022-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/impact of AI on POINT OF CARE DIAGNOSTICS MARKET Industry Trends
Chapter 5. Point of Care Diagnostics Market Segmentation 1: By Products, Estimates & Trend Analysis
5.1. Market Share by Products, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Products:
5.2.1. Glucose Monitoring Products
5.2.1.1. Glucose Monitoring Strips
5.2.1.2. Glucose Monitoring Meters
5.2.1.3. Glucose Monitoring Lancets & Lancing Devices
5.2.2. Cardiometabolic Monitoring Products
5.2.2.1. Cardiac Marker Testing Products
5.2.2.2. Blood Gas/Electrolyte Testing Products
5.2.2.3. HbA1c Testing Products
5.2.3. Infectious Disease Testing Products
5.2.3.1. Respiratory Infection Testing Products
5.2.3.1.1. Influenza Testing Products
5.2.3.1.2. Tuberculosis
5.2.3.1.3. Other Respiratory Infections
5.2.3.2. Healthcare-Associated Infection Testing Products
5.2.3.3. Tropical Disease Testing Products
5.2.3.4. Sexually Transmitted Disease Testing Products
5.2.3.4.1. HIV Testing Products
5.2.3.4.2. Hepatitis Testing Products
5.2.3.4.3. Syphilis Testing Products
5.2.3.4.4. Human Papillomavirus Testing Products
5.2.3.4.5. Chlamydia trachomatis Testing Products
5.2.3.4.6. Neisseria gonorrhoeae Testing Products
5.2.3.4.7. Herpes Simplex Virus Testing Products
5.2.3.5. Clostridium difficile Infection Testing Products
5.2.3.6. Other Infectious Disease Testing Products
5.2.4. Coagulation Monitoring Products
5.2.4.1. PT/INR Testing Products
5.2.4.2. ACT/APTT Testing Products
5.2.5. Pregnancy & Fertility Testing Products
5.2.5.1. Pregnancy Testing Products
5.2.5.2. Fertility Testing Products
5.2.6. Tumor/Cancer Marker Testing Products
5.2.7. Urinalysis Testing Products
5.2.8. Cholesterol Testing Products
5.2.9. Hematology Testing Products
5.2.10. Drugs-of-Abuse Testing Products
5.2.11. Thyroid-Stimulating Hormone Testing Products
5.2.12. Fecal Occult Testing Products
5.2.13. Other Products
Chapter 6. Point of Care Diagnostics Market Segmentation 2: By Mode of Purchase, Estimates & Trend Analysis
6.1. Market Share by Mode of Purchase, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Mode of Purchase:
6.2.1. Prescription-Based Testing Products
6.2.2. Over-the-Counter (OTC) Testing Product
Chapter 7. Point of Care Diagnostics Market Segmentation 3: By Technology, Estimates & Trend Analysis
7.1. Market Share by Technology, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Technology:
7.2.1. Biochemistry
7.2.2. Immunoassays
7.2.3. Molecular Diagnostics
7.2.3.1. RT-PCR
7.2.3.2. INAAT
Chapter 8. Point of Care Diagnostics Market Segmentation 4: By Sample Type, Estimates & Trend Analysis
8.1. Market Share by Sample Type, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Sample Type:
8.2.1. Blood Samples
8.2.2. Nasal & Oropharyngeal Swabs
8.2.3. Urine Samples
8.2.4. Other Samples
Chapter 9. Point of Care Diagnostics Market Segmentation 5: By End-users, Estimates & Trend Analysis
9.1. Market Share by End-users, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following End-users:
9.2.1. Home Care/Self Testing
9.2.2. Physician offices & Outpatient/Ambulatory Care Settings
9.2.3. Hospitals
9.2.4. Research Laboratories
Chapter 10. Point of Care Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Point of Care Diagnostics Market, Regional Snapshot 2022 - 2035
10.2. North America
10.2.1. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022 - 2035
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2022 - 2035
10.2.3. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2022 - 2035
10.2.4. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022 - 2035
10.2.5. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2022 - 2035
10.2.6. North America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2022 - 2035
10.3. Europe
10.3.1. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022 - 2035
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2022 - 2035
10.3.3. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2022 - 2035
10.3.4. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022 - 2035
10.3.5. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2022 - 2035
10.3.6. Europe Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2022 - 2035
10.4. Asia Pacific
10.4.1. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022 - 2035
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2022 - 2035
10.4.3. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2022 - 2035
10.4.4. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022 - 2035
10.4.5. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts By Sample Type, 2022 - 2035
10.4.6. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2022 - 2035
10.5. Latin America
10.5.1. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022 - 2035
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2022 - 2035
10.5.3. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2022 - 2035
10.5.4. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022 - 2035
10.5.5. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2022 - 2035
10.5.6. Latin America Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2022 - 2035
10.6. Middle East & Africa
10.6.1. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2022 - 2035
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Products, 2022 - 2035
10.6.3. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Mode of Purchase, 2022 - 2035
10.6.4. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022 - 2035
10.6.5. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Sample Type, 2022 - 2035
10.6.6. Middle East & Africa Point of Care Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2022 - 2035
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Dickinson, And Company (Bd)
11.2.3. Chembio Diagnostic Systems, Inc.
11.2.4. Danaher Corporation
11.2.5. Ekf Diagnostics Holdings Plc
11.2.6. Werfenlife, S.A.
11.2.7. Johnson & Johnson Services, Inc.
11.2.8. Nova Biomedical
11.2.9. Hoffmann-La Roche Ltd.
11.2.10. Sekisui Chemical Co. Ltd.
11.2.11. Quidel Corporation
11.2.12. Siemens Ag
11.2.13. Trinity Biotech
11.2.14. Accubiotech Co., Ltd.
11.2.15. Other Key Players.
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Point of Care Diagnostics Market Size is valued at USD 16.25 Billion in 2025 and is predicted to reach USD 38.87 Billion by the year 2035.
Point of Care Diagnostics Market is expected to grow at an 9.60% CAGR during the forecast period for 2026-2035.
Abbott Laboratories, Nova Biomedical, Chembio Diagnostic Systems, Inc., Danaher Corporation, Ekf Diagnostics Holdings Plc, Werfenlife, S.A., J&J.
point of care diagnostics market can be segmented on the basis of products, Platform, mode of purchase, technology, sample type, end-users, and region.
North American region is leading the Point of Care Diagnostics Market.